Robert Boigegrain

897 total citations
18 papers, 761 citations indexed

About

Robert Boigegrain is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Robert Boigegrain has authored 18 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in Robert Boigegrain's work include Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (9 papers) and Chemical Synthesis and Analysis (3 papers). Robert Boigegrain is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (9 papers) and Chemical Synthesis and Analysis (3 papers). Robert Boigegrain collaborates with scholars based in France, Italy and Belgium. Robert Boigegrain's co-authors include Martine Poncelet, Michel Héaulme, Christiane Gueudet, D. Gully, Roger Leyris, Aline Brouard, Philippe Soubrié, Danielle Gully, Patrick Kitabgi and André Bachy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

In The Last Decade

Robert Boigegrain

17 papers receiving 733 citations

Peers

Robert Boigegrain
Comparison fields: 5 of 66
  • Cellular and Molecular Neuroscience 605
  • Molecular Biology 560
  • Reproductive Medicine 133
  • Physiology 93
  • Organic Chemistry 58
Christine Batzl‐Hartmann Germany
H. YAJIMA Japan
D. Gully France
Kelly P. Longo United States
J.B. Bøler United States
Fredric J. Vinick United States
Bernard Labeeuw France
J P Moreau United States
Larry S. Birkemo United States
D. Roemer Japan
Christine Batzl‐Hartmann Germany View profile →
Citations per field, relative to Robert Boigegrain
Robert Boigegrain · 1×
Citations per year, relative to Robert Boigegrain
Robert Boigegrain · 1×

Countries citing papers authored by Robert Boigegrain

Since Specialization
Citations

This map shows the geographic impact of Robert Boigegrain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Boigegrain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Boigegrain more than expected).

Fields of papers citing papers by Robert Boigegrain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Boigegrain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Boigegrain. The network helps show where Robert Boigegrain may publish in the future.

Co-authorship network of co-authors of Robert Boigegrain

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Boigegrain. A scholar is included among the top collaborators of Robert Boigegrain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Boigegrain. Robert Boigegrain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
# Title Journal Authors Indexed citations
1 SR146131: A New Potent, Orally Active, and Selective Nonpeptide Cholecystokinin Subtype 1 Receptor Agonist. II: In Vivo Pharmacological Characterization Journal of Pharmacology and Experimental Therapeutics Richard Alonso, M. Arnone et al. 25
2 X-ray structural characterization of SR 142948, a novel potent synthetic neurotensin receptor antagonist Bioorganic & Medicinal Chemistry Letters Luc Quéré, Robert Boigegrain et al. 8
3 Biochemical and Pharmacological Activities of SR 142948A, a New Potent Neurotensin Receptor Antagonist Journal of Pharmacology and Experimental Therapeutics Danielle Gully, Bernard Labeeuw et al. 181
4 Structural requirements of non-peptide neurotensin receptor antagonists Journal of the Chemical Society Perkin Transactions 2 Luc Quéré, Robert Boigegrain et al. 11
5 NEW POTENT AND SELECTIVE NON-PEPTIDE ANTAGONISTS OF NEUROTENSIN RECEPTORS European Journal of Medicinal Chemistry Jean‐Pierre Maffrand, Robert Boigegrain et al. 2
6 SR 46559A, AN ATYPICAL MUSCARINIC COMPOUND WITH NO CHOLINERGIC SYNDROME : CHEMICAL APPROACH AND PHARMACOLOGICAL PROFILE European Journal of Medicinal Chemistry Robert Boigegrain, Philippe Soubrié et al. 1
7 Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonists European Journal of Pharmacology Mounia Azzi, Danielle Gully et al. 25
8 Synthesis and β-adrenergic activity of atypical β-adrenergic phenylethanolaminotetralin stereoisomers European Journal of Medicinal Chemistry R. Cecchi, Tiziano Croci et al. 28
9 SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome Psychopharmacology R. Steinberg, Florence Oury-Donat et al. 8
10 Neurotensin receptor agonists and antagonists Drugs of the Future J.P. Maffrand, D. Gully et al. 6
11 Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proceedings of the National Academy of Sciences D. Gully, Robert Boigegrain et al. 384
12 SR 46559 A and related aminopyridazines are potent muscarinic agonists with no cholinergic syndrome Bioorganic & Medicinal Chemistry Letters Camille G. Wermuth, Jean‐Jacques Bourguignon et al. 17
13 Inhibition of rat colon motility by stimulation of atypical beta-adrenoceptors with new gut-specific agents Pharmacological Research Communications Tiziano Croci, R. Cecchi et al. 30
14 Syntheses of 2-Alkyl-3-(4-dialkylaminoalkoxy-benzoyl)-thieno[3,2-c]pyridines Heterocycles D. FREHEL, Robert Boigegrain et al. 4
15 Kappa binding sites in guinea-pig brain membranes: Evidence for a dynorphin-resistant subtype Life Sciences Michel Morre, André Bachy et al. 18
16 Analgesia, new research approaches. PubMed Michel Morre, Robert Boigegrain et al. 1
17 Nouvelles voies d'accès à des aryl‐4 thiéno[2,3‐c]pyridines et à des aryl‐7 thiéno[3,2‐c]pyridines Journal of Heterocyclic Chemistry Jean‐Pierre Maffrand, Robert Boigegrain et al. 5
18 New Synthesis of Thieno[3,2-c]pyridines Heterocycles Jean‐Pierre Maffrand, Robert Boigegrain 7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026